| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Molecular Medicine/Institute of Biotechnology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245 [S-S. F. Y., S-Y. L., G. C., M. S., E. Y-H. P. L.], and Department of Pediatrics and the Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas 75235 [G. E. T.]
Mutations in BRCA1 and BRCA2 account for the majority of familial breast cancers. Cells with mutated BRCA1 or BRCA2 are hypersensitive to ionizing radiation (IR) and exhibit defective DNA repair. Both BRCA1 and BRCA2 have been reported to bind Rad51, a protein essential for homologous recombination and the recombinational repair of DNA double-strand breaks. In normal cells, a redistribution of Rad51 protein, manifested as formation of Rad51 nuclear foci, is seen upon IR treatment. Here we demonstrate that IR-induced Rad51 foci formation is aberrant in BRCA2- but not BRCA1-deficient tumor cells. In Capan-1 cells, which do not express functional BRCA2, there was little Rad51 foci formation in response to a wide range of radiation dosages. Moreover, forced expression of a fusion protein containing green fluorescent protein and the first Rad51-binding BRC repeat of BRCA2 in cells with wild-type BRCA2 rendered them hypersensitive to IR and cisplatin and compromised IR-induced Rad51 foci formation. In HCC1937 cells, which harbor mutation of BRCA1, IR-induced Rad51 foci were readily detected. This study suggests a requirement of BRCA2 protein for the IR-induced assembly of Rad51 complex in vivo.
This article has been cited by other articles:
![]() |
T. Hucl, C. Rago, E. Gallmeier, J. R. Brody, M. Gorospe, and S. E. Kern A Syngeneic Variance Library for Functional Annotation of Human Variation: Application to BRCA2 Cancer Res., July 1, 2008; 68(13): 5023 - 5030. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Evers, R. Drost, E. Schut, M. de Bruin, E. van der Burg, P. W.B. Derksen, H. Holstege, X. Liu, E. van Drunen, H. B. Beverloo, et al. Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin Clin. Cancer Res., June 15, 2008; 14(12): 3916 - 3925. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Park, H.-W. Yoo, B.-R. Kim, R. Park, S.-Y. Choi, and Y. Kim Identification of a novel human Rad51 variant that promotes DNA strand exchange Nucleic Acids Res., June 1, 2008; 36(10): 3226 - 3234. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nomme, Y. Takizawa, S. F. Martinez, A. Renodon-Corniere, F. Fleury, P. Weigel, K.-i. Yamamoto, H. Kurumizaka, and M. Takahashi Inhibition of filament formation of human Rad51 protein by a small peptide derived from the BRC-motif of the BRCA2 protein. Genes Cells, May 1, 2008; 13(5): 471 - 481. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Coic, T. Feldman, A. S. Landman, and J. E. Haber Mechanisms of Rad52-Independent Spontaneous and UV-Induced Mitotic Recombination in Saccharomyces cerevisiae Genetics, May 1, 2008; 179(1): 199 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Swisher, W. Sakai, B. Y. Karlan, K. Wurz, N. Urban, and T. Taniguchi Secondary BRCA1 Mutations in BRCA1-Mutated Ovarian Carcinomas with Platinum Resistance Cancer Res., April 15, 2008; 68(8): 2581 - 2586. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Kauff Is It Time to Stratify for BRCA Mutation Status in Therapeutic Trials in Ovarian Cancer? J. Clin. Oncol., January 1, 2008; 26(1): 9 - 10. [Full Text] [PDF] |
||||
![]() |
Y. Tan, P. Raychaudhuri, and R. H. Costa Chk2 Mediates Stabilization of the FoxM1 Transcription Factor To Stimulate Expression of DNA Repair Genes Mol. Cell. Biol., February 1, 2007; 27(3): 1007 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Barroso, R.L. Milne, L.P. Fernandez, P. Zamora, J.I. Arias, J. Benitez, and G. Ribas FANCD2 associated with sporadic breast cancer risk Carcinogenesis, September 1, 2006; 27(9): 1930 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Kennedy and A. D. D'Andrea DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes J. Clin. Oncol., August 10, 2006; 24(23): 3799 - 3808. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Saeki, N. Siaud, N. Christ, W. W. Wiegant, P. P. W. van Buul, M. Han, M. Z. Zdzienicka, J. M. Stark, and M. Jasin Suppression of the DNA repair defects of BRCA2-deficient cells with heterologous protein fusions PNAS, June 6, 2006; 103(23): 8768 - 8773. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Schlegel, F. M. Jodelka, and R. Nunez BRCA1 Promotes Induction of ssDNA by Ionizing Radiation. Cancer Res., May 15, 2006; 66(10): 5181 - 5189. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Filippo, P. Chi, M. G. Sehorn, J. Etchin, L. Krejci, and P. Sung Recombination Mediator and Rad51 Targeting Activities of a Human BRCA2 Polypeptide J. Biol. Chem., April 28, 2006; 281(17): 11649 - 11657. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. McAllister, C. D. Houle, J. Malphurs, T. Ward, N. K. Collins, W. Gersch, L. Wharey, J. C. Seely, L. Betz, L. M. Bennett, et al. Spontaneous and Irradiation-Induced Tumor Susceptibility in Brca2 Germline Mutant Mice and Cooperative Effects with a p53 Germline Mutation Toxicol Pathol, February 1, 2006; 34(2): 187 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Martin, N. Winkelmann, M. I. R. Petalcorin, M. J. McIlwraith, and S. J. Boulton RAD-51-Dependent and -Independent Roles of a Caenorhabditis elegans BRCA2-Related Protein during DNA Double-Strand Break Repair Mol. Cell. Biol., April 15, 2005; 25(8): 3127 - 3139. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lu, X. Guo, X. Meng, J. Liu, C. Allen, J. Wray, J. A. Nickoloff, and Z. Shen The BRCA2-Interacting Protein BCCIP Functions in RAD51 and BRCA2 Focus Formation and Homologous Recombinational Repair Mol. Cell. Biol., March 1, 2005; 25(5): 1949 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hatanaka, M. Yamazoe, J. E. Sale, M. Takata, K. Yamamoto, H. Kitao, E. Sonoda, K. Kikuchi, Y. Yonetani, and S. Takeda Similar Effects of Brca2 Truncation and Rad51 Paralog Deficiency on Immunoglobulin V Gene Diversification in DT40 Cells Support an Early Role for Rad51 Paralogs in Homologous Recombination Mol. Cell. Biol., February 1, 2005; 25(3): 1124 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wu, S. R. Hinson, A. Ohashi, D. Farrugia, P. Wendt, S. V. Tavtigian, A. Deffenbaugh, D. Goldgar, and F. J. Couch Functional Evaluation and Cancer Risk Assessment of BRCA2 Unclassified Variants Cancer Res., January 15, 2005; 65(2): 417 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Miller, J. M. Hinz, N.A. Yamada, L. H. Thompson, and J. S. Albala Nuclear localization of Rad51B is independent of Rad51C and BRCA2 Mutagenesis, January 1, 2005; 20(1): 57 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Schoenfeld, S. Apgar, G. Dolios, R. Wang, and S. A. Aaronson BRCA2 Is Ubiquitinated In Vivo and Interacts with USP11, a Deubiquitinating Enzyme That Exhibits Prosurvival Function in the Cellular Response to DNA Damage Mol. Cell. Biol., September 1, 2004; 24(17): 7444 - 7455. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, P. R. Andreassen, and A. D. D'Andrea Functional Interaction of Monoubiquitinated FANCD2 and BRCA2/FANCD1 in Chromatin Mol. Cell. Biol., July 1, 2004; 24(13): 5850 - 5862. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hussain, J. B. Wilson, A. L. Medhurst, J. Hejna, E. Witt, S. Ananth, A. Davies, J.-Y. Masson, R. Moses, S. C. West, et al. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways Hum. Mol. Genet., June 15, 2004; 13(12): 1241 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Han, S. E. Hankinson, H. Ranu, I. De Vivo, and D. J. Hunter Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study Carcinogenesis, February 1, 2004; 25(2): 189 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. van der Heijden, R. H. Hruban, and S. E. Kern Reply Cancer Res., October 15, 2003; 63(20): 6999 - 7001. [Full Text] [PDF] |
||||
![]() |
K. Yamamoto, M. Ishiai, N. Matsushita, H. Arakawa, J. E. Lamerdin, J.-M. Buerstedde, M. Tanimoto, M. Harada, L. H. Thompson, and M. Takata Fanconi Anemia FANCG Protein in Mitigating Radiation- and Enzyme-Induced DNA Double-Strand Breaks by Homologous Recombination in Vertebrate Cells Mol. Cell. Biol., August 1, 2003; 23(15): 5421 - 5430. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, P. D. Jeffrey, J. Miller, E. Kinnucan, Y. Sun, N. H. Thoma, N. Zheng, P.-L. Chen, W.-H. Lee, and N. P. Pavletich BRCA2 Function in DNA Binding and Recombination from a BRCA2-DSS1-ssDNA Structure Science, September 13, 2002; 297(5588): 1837 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. U. De Silva, P. J. McHugh, P. H. Clingen, and J. A. Hartley Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin Nucleic Acids Res., September 1, 2002; 30(17): 3848 - 3856. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. French, J.-Y. Masson, C. S. Griffin, P. O'Regan, S. C. West, and J. Thacker Role of Mammalian RAD51L2 (RAD51C) in Recombination and Genetic Stability J. Biol. Chem., May 24, 2002; 277(22): 19322 - 19330. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Jackson Sensing and repairing DNA double-strand breaks Carcinogenesis, May 1, 2002; 23(5): 687 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Venkitaraman Functions of BRCA1 and BRCA2 in the biological response to DNA damage J. Cell Sci., March 12, 2002; 114(20): 3591 - 3598. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kraakman-van der Zwet, W. J. I. Overkamp, R. E. E. van Lange, J. Essers, A. van Duijn-Goedhart, I. Wiggers, S. Swaminathan, P. P. W. van Buul, A. Errami, R. T. L. Tan, et al. Brca2 (XRCC11) Deficiency Results in Radioresistant DNA Synthesis and a Higher Frequency of Spontaneous Deletions Mol. Cell. Biol., January 15, 2002; 22(2): 669 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sonoda, M. Takata, Y. M. Yamashita, C. Morrison, and S. Takeda Homologous DNA recombination in vertebrate cells PNAS, July 17, 2001; 98(15): 8388 - 8394. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Gasior, H. Olivares, U. Ear, D. M. Hari, R. Weichselbaum, and D. K. Bishop Assembly of RecA-like recombinases: Distinct roles for mediator proteins in mitosis and meiosis PNAS, July 17, 2001; 98(15): 8411 - 8418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Greenblatt, P. O. Chappuis, J. P. Bond, N. Hamel, and W. D. Foulkes TP53 Mutations in Breast Cancer Associated with BRCA1 or BRCA2 Germ-line Mutations: Distinctive Spectrum and Structural Distribution Cancer Res., May 1, 2001; 61(10): 4092 - 4097. [Abstract] [Full Text] |
||||
![]() |
M. Takata, M. S. Sasaki, S. Tachiiri, T. Fukushima, E. Sonoda, D. Schild, L. H. Thompson, and S. Takeda Chromosome Instability and Defective Recombinational Repair in Knockout Mutants of the Five Rad51 Paralogs Mol. Cell. Biol., April 15, 2001; 21(8): 2858 - 2866. [Abstract] [Full Text] |
||||
![]() |
M. Takata, M. S. Sasaki, E. Sonoda, T. Fukushima, C. Morrison, J. S. Albala, S. M. A. Swagemakers, R. Kanaar, L. H. Thompson, and S. Takeda The Rad51 Paralog Rad51B Promotes Homologous Recombinational Repair Mol. Cell. Biol., September 1, 2000; 20(17): 6476 - 6482. [Abstract] [Full Text] |
||||
![]() |
V. P.C.C. Yu, M. Koehler, C. Steinlein, M. Schmid, L. A. Hanakahi, A. J. van Gool, S. C. West, and A. R. Venkitaraman Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation Genes & Dev., June 1, 2000; 14(11): 1400 - 1406. [Abstract] [Full Text] |
||||
![]() |
A. Bhattacharyya, U. S. Ear, B. H. Koller, R. R. Weichselbaum, and D. K. Bishop The Breast Cancer Susceptibility Gene BRCA1 Is Required for Subnuclear Assembly of Rad51 and Survival following Treatment with the DNA Cross-linking Agent Cisplatin J. Biol. Chem., July 28, 2000; 275(31): 23899 - 23903. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wu, S.-W. Jiang, M. Thangaraju, G. Wu, and F. J. Couch Induction of the BRCA2 Promoter by Nuclear Factor-kappa B J. Biol. Chem., November 3, 2000; 275(45): 35548 - 35556. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O'Regan, C. Wilson, S. Townsend, and J. Thacker XRCC2 Is a Nuclear RAD51-like Protein Required for Damage-dependent RAD51 Focus Formation without the Need for ATP Binding J. Biol. Chem., June 15, 2001; 276(25): 22148 - 22153. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |